Results: 2

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review

Braz. j. med. biol. res; 51 (8), 2018
Considering that osteoarthritis (OA) is the most prevalent joint disease worldwide, multiple pharmacological treatments have been proposed to alter the articular structure with potential benefit in the progression of the disease. The so-called disease-modifying OA drugs have been frequently investigated ...

Resultados da terapia antiagregante com ticlopidina em pacientes portadores de ulceraçöes tróficas de membros inferiores
Antiaggregant therapy results with ticlopidine in patients with trophic ulcerations of the lower limbs

Folha med; 91 (1), 1985
Dezessete pacientes internados, portadores de ulceraçöes tróficas das extremidades, por arteriosclerose obliterante e/ou síndrome pós-flebítica, foram tratados durante 4 meses com ticlopidina VO, na dose de 500 mg/dia. Os pacientes foram avaliados clínica e laboratorialmente, observando-se, ao fin...